Skip to content
User

Ole Andreas Halvorsen

Viking Global Investors

Ole Andreas Halvorsen Viela Bio Inc stake

total: 670

Viking Global Investors VIE trades

Total transactions:
6
New positions:
1
Sold out:
1
Reduced:
4
Held since:
2019 Q4
Held for:
5 quarters
Latest activity:
2021 Q1
According to 2026 Q2 report, Ole Andreas Halvorsen doesn't hold any Viela Bio Inc (VIE) shares. To date, the estimated cost basis is nearly $27.15 for "buy" trades and estimated average "sell" price is $36.19. Viking Global Investors first purchased VIE in 2019 Q4, initially acquiring about 1.49M shares. Since the initial investment in Viela Bio Inc (VIE), Viking Global Investors has made 5 more transactions.

When did Ole Andreas Halvorsen sell Viela Bio Inc (VIE)?

Ole Andreas Halvorsen sold off the entire Viela Bio Inc (VIE) position in 2021 Q1.

When did Ole Andreas Halvorsen buy Viela Bio Inc (VIE)?

Ole Andreas Halvorsen first invested in Viela Bio Inc (VIE) in 2019 Q4 at the reported quarter-end price of $27.15 per share.

What's the cost basis of Viking Global Investors's VIE stake?

The estimated cost basis for Viela Bio Inc (VIE) stake is around $27.15 per share. This represents their average reported price* across all buy transactions

Estimated cost basis*

Weighted AVG buy price:
$27.15
Weighted AVG sell price:
$36.19

Ole Andreas Halvorsen's historical trades in Viela Bio Inc

6 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2021 Q1
0.00%
0
$35.97
-100% (-703,424)
-0.07%
2020 Q4
0.07%
$35.97
-16.56% (-139,576)
2020 Q3
0.09%
$28.08
-19.64% (-206,000)
2020 Q2
0.20%
$43.32
-16.08% (-201,000)
2020 Q1
0.25%
$38.00
-15.96% (-237,329)
2019 Q4
0.19%
$27.15
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.